How to Cut Clinical Study Build Times By 50 percent — Modern Lessons Learned by Syneos Health
About this webinar
Building a clinical trial involves a host of logistical and manual operations as part of the overall process. Leveraging technology available today, Syneos Health has been able to modernize their approach shortening their clinical study build times by 50 percent. Automation is the key, shortening time consuming manual operations as part of the electronic data capture (EDC) process. Syneos is also implementing new solutions to aggregate and clean trial data more efficiently and provide analysis-ready data at all times.
Join the featured speaker to hear lessons learned about cutting clinical study build times by 50 percent.
Who should attend
- Clinical Data Management
- Data Management
- Clinical Science
- Clinical Development
- Biometrics
- Biostatistics
- Informatics
What you will learn
- Learn how to shorten clinical trial build times
- Learn how to modernize the next clinical trial build
- Learn how new electronic data capture (EDC) automation and leveraging data aggregation and cleaning tools can streamline manual processes
Featured Speakers
Trevor Griffiths
Trevor Griffiths, as a senior leader within Syneos’ Biometrics group, is responsible for overseeing Biometrics partnerships with their strategic partners. Griffiths has been with Syneos Health for over 24 years serving in many leadership positions within data management, programming, biostatistics and medical writing. He has a strong technical background in operational delivery and has worked across the majority of industry leading systems and rolled out & implemented a multitude of service solutions for Syneos’ strategic partners. Griffiths also led the implementation of Veeva CDMS within Syneos Health.
Partner for this event
Veeva
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,100 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit www.veeva.com.
Related webinars
More from Veeva.
Unifying GxP Compliance: Digital Strategies for Biopharma Quality Systems
Assignment-Free Training – Cultivating a Training-Positive Mindset
Effective Pharmacovigilance Content Collaboration with Cloud Technologies
Reshaping Global ICSR Reporting to Deliver Real-Time Visibility and Oversight
Best Practice Strategies to Make the Move to a Modern CTMS
Unifying Adverse Event Data with Cloud-based Integrations
How EQRx Improved Site Engagement During Study Start-Up
Oncology Trial Complexity: New Tufts CSDD Research and Strategies to Optimize Study Design
Harmonizing QA & RA in MedTech: Epredia’s Journey
Accelerating Toward a New Era of Clinical Trials: Fireside Chat with Celerion
PICI’s Best Practices for Building Oncology Studies in an EDC
Driving Trial Efficiency, Speed, and Quality: AstraZeneca’s Clinical Transformation Journey